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Abstract
We investigated the modulating effect of vitamin E on pulmonary polyamine biosynthesis, cell proliferation and
carcinogenesis in mice treated with urethane. Pulmonary ornithine decarboxylase induction and subsequent polyamine
accumulation were observed during the initiation and promotion phases of the urethane-induced lung carcinogenesis in
mice. The increases of ODC activity and polyamine level during both phases were almost inhibited when a high vitamin E
diet was provided. The urethane-increased level of pulmonary proliferating cell nuclear antigen as a marker of cell
proliferation during the carcinogenesis was inhibited by vitamin E treatment. Also, vitamin E suppressed the urethane-in-
duced elevation of pulmonary cyclooxygenase activity as a marker of tumor promotion. In conjugation with these events,
vitamin E reduced the development of lung tumors in mice treated with urethane. These results indicated that vitamin E
could act as a useful chemopreventive agent against lung carcinogenesis in mice due to the regulation of cell proliferation.
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1. Introduction
 .Polyamine putrescine, spermidine and spermine
play important roles in cell growth processes, and
proliferation of tissue with low concentration of
w xpolyamine is weak 1,2 . Ornithine decarboxylase
 .ODC is the rate-limiting enzyme, which appears to
be closely associated with normal and neoplastic cell
w xproliferation 3–5 . The regulation of ODC activity in
normal tissue is rigid, but the regulation in human
carcinomas is to be uncontrollable based on its muta-
w xtion 6 , leading to the stimulation of polyamine
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biosynthesis and subsequent abnormal cell prolifera-
tion. These reports indicate that aberrations in
polyamine biosynthesis are closely related to the
development of tumors. Thus, correcting the abnor-
mality of polyamine biosynthesis during carcino-
genesis may contribute to the prevention of the car-
cinogenesis. In fact, DL-a-difluoromethylornithine,
which is a irreversible inhibitor of ODC, has been
reported to inhibit chemical carcinogenesis in many
w xtissues 7,8 .
Many epidemiological and experimental studies
show that vitamin E can reduce cancer risk in some
w xorgans 9 . The lipophilic vitamin E is considered as
one of the most effective endogenous antioxidants
working in the lipid layers of membranes to avoid
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w xlipid peroxidation 10 , and this antioxidative effect
presumably contributes to the prevention from car-
w xcinogenesis by vitamin E 11 . Also, anti-tumor effect
of vitamin E may be attributed to its capacity, being a
lipophilic molecule, to insert into the lipid bilayer
thereby completely altering membrane lipid biochem-
istry, leading to disruption of signal transduction
related to cell proliferation through the plasma mem-
w xbrane 12 . Thus, vitamin E may inhibit cell prolifera-
tion during carcinogenesis due to these actions.
Since the recently increased trend of lung cancer in
w xJapan has become a public health problem 13 , we
have investigated the usefulness of vitamin E as a
chemopreventive agent against lung cancer by using
w xa mouse lung tumor model 14 . In this study, we
attempted to estimate if vitamin E could suppress the
development of lung tumors due to the modulation of
polyamine biosynthesis and subsequent cell prolifera-
tion during the initiation and promotion phases of the
urethane-induced lung carcinogenesis in mice.
2. Materials and methods
2.1. Chemicals
w 14 x  . w 14 xL- 1- C Ornithine 53 Cirmol and 1- C acetyl
 .coenzyme A 50 Cirmol were purchased from
 .Amersham International Buckinghamshire, UK .
 .Polyvinyldifluoride PVDF membrane was from
 .Nippon Genetics Co. Tokyo, Japan ; monoclonal
 .anti-proliferating cell nuclear antigen PCNA was
 .from Dakopatts Glostrup, Denmark ; anti-mouse im-
munoglobulin G conjugated with horseradish peroxi-
 .dase was from Pel-Freez Arkansas, USA and West-
ern blot chemiluminescence reagent was from Dupont
 .NEN Boston, MA, USA . Bio-Rad protein assay kit
 .was from Bio-Rad Richmond, VA, USA . Aprotinin,
Nonidet P-40, phenylmethylsulfonyl fluoride, and
urethane were purchased from Sigma Chemical Co.
 .St. Louis, MO, USA . All the other chemicals used
were of the highest purity from Wako Pure Chemi-
 .cals Osaka, Japan .
2.2. Animals and treatment
The animals used were 6-week-old male mice,
specific pathogen-free ddY strain, purchased from
Japan SLC, Shizuoka, Japan. The mice were kept in
temperature- and humidity-controlled animals facili-
 .ties 22"18C, 55"5% relative humidity under 12
h light-12 h dark cycle. The mice were fed a control
 X.CE-2 diet or a excess vitamin E-fed CE-2 CE-2 diet
 .Japan Clea, Tokyo, Japan . The contents of a-
tocopherol were 25 and 500 mgrkg, respectively.
The dose of vitamin E was selected based on our
w xprevious report 14 . Sterilized water was given ad
libitum. Urethane was dissolved in sterilized saline,
and the mice were given the urethane solution at a
dose of 750 mgrkg body weight by a single i.p.
injection.
2.3. Experimental procedure
At first experiment, Time course of changes in
pulmonary ODC activities at days 3, 7, 14, 28, 49
and 70 after urethane injection was followed in order
to clarify initiation and promotion phases of the
carcinogenic process.
At second experiment, The effect of vitamin E on
polyamine biosynthesis and cell proliferation through
initiation and promotion phases of urethane-induced
lung carcinogenesis was checked. The mice were
divided into three groups, that is, control group,
urethane-treated group and urethane-treated plus vita-
min E-fed groups. At 6 weeks of age, feeding the diet
in each group was started. On the eighth day after the
start of the feeding, each group was given urethane or
vehicle. At days 3, 14 and 70 after the injection, the
mice were sacrificed in order to estimate pulmonary
ODC activity, polyamine level and PCNA level. Also,
we determined cyclooxygenase activity as a marker
of tumor promotion at day 70 after the injection.
At third experiment, we estimated if the change of
polyamine level could relate to the level of PCNA in
urethane-induced lung carcinogenesis. The mice were
fed excess vitamin E for 7 days before urethane
injection. Putrescine-HCl dissolved in saline 10
.molerkg, s.c. or vehicle were given at 12, 36 and 60
h after the injection. Pulmonary PCNA level was
determined at 12 h after final treatment of putrescine.
Since this treatment could pulmonary polyamine level
in urethane-treated plus vitamin E-fed group up to the
level in urethane-treated group, we selected this treat-
ment condition.
At final experiment, the effect of vitamin E on
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urethane-induced lung carcinogenesis in mice was
checked. At the 25 week after the injection, all mice
in the three groups mentioned above were sacrificed
to confirm the development of lung tumors.
2.4. ODC acti˝ity and polyamine le˝el
A 20% lung homogenate was prepared in 0.05 M
 .Tris-HCl-0.25 M sucrose pH 7.5 . The homogenate
was centrifuged at 100 000=g for 30 min, and the
supernatant was assayed for ODC activity by mea-
surement of the amount of radioactive CO liberated2
w 14 x w xfrom L- 1- C ornithine 15 . The assay mixture of
w 14 xODC activity contained 0.4 mM L- 1- C ornithine
 . X0.125 mCi , 0.18 mM pyridoxal-5 -phosphate, 0.25
mM EDTA, 2 mM dithiothreitol, 25 mM sucrose, 50
 .mM Tris-HCl pH 7.5 , and enzyme source in a final
volume of 0.1 ml.
A 20% lung homogenate was prepared in ice-cold
5% trichloroacetic acid. Polyamine concentration was
analyzed by HPLC equipped with fluorescence detec-
w xtor 16 . The separation of polyamine was carried out
on a STR ODS-II column Shimazu Techno-Re-
.search, Kyoto, Japan with a solvent composed of 10
mM hexanesulfonic acid sodium saltr100 mM
sodium perchloric acid as solvent A and the solvent
 .Armethanol 1:3 as solvent B. The sample was
eluted with 96% of the solvent A and 4% of the
solvent B for 3 min and then with a programmed
solvent gradient using the liner gradient curve. The
gradient changed from 4% to 55% of the solvent B in
22 min at a flow-rate of 0.7 mlrmin. DNA content
w xwas determined by a fluorometric assay 17 .
2.5. Cyclooxygenase acti˝ity
A 20% lung homogenate was prepared in 100 mM
 .Tris-HCl buffer pH 7.5 . The microsomal fraction
from the homogenate was isolated by differential
w xcentrifugation 18 , and the fraction was assay for
cyclooxygenase activity by measurement of the
 .amount of prostaglandin E PGE2 generated from2
arachidonic acid. The assay mixture of cyclooxy-
genase activity contained 20 mM arachidonic acid, 1
mM epinephrine, 1 mM glutathione, 50 mM Tris-HCl
 .pH 7.5 , and enzyme source in a final volume of
0.15 ml. After incubation for 15 min at 378C, pH of
the reaction mixture was adjusted to 3.0 with 0.2 N
HCl, and PGE2 was extracted with ethylacetate. The
extracted sample was passed through a SEP-PAK C18
 .column Waters Associates, Milford, PA, USA , and
w xthe methanol elute was then evaporated 19 . PGE2
content in the residue was estimated by using a
 .ELISA system Cayman Chemical, MI, USA .
2.6. Western blot analysis of PCNA le˝el
A 20% homogenate was prepared in Tris-HCl pH
.7.5 containing 1% Nonidet P-40, 0.5% sodium de-
 .oxycholate, 0.1% sodium dodecyl sulfate SDS , 0.15
M NaCl, 1 mM EDTA, 100 mg aprotinin, and
phenylmethylsulfonyl fluoride. Nuclear proteins were
extracted from the homogenate according to the pre-
w xvious method 20 . SDS-polyacrylamide gel elec-
trophoresis and western blot analysis were performed
w xaccording to established methods 21,22 . Briefly, 20
mg of protein ran on 12.5% SDS-polyacrylamide gel
and was transferred to PVDF membrane. After elec-
trophoretic transference, the membrane was blocked
overnight at 48C with 0.5% casein. Then the mem-
brane was washed with Tris-buffered saline contain-
 .ing 0.05% Tween 20 TBST and incubated in anti-
PCNA. After the incubation with the primary anti-
body, the membrane was washed with TBST and
incubated with anti-mouse immunoglobulin G conju-
gated with horse radish peroxidase. After extensive
washing with TBST, the blots were developed with a
chemiluminescence detection system.
2.7. The estimation of lung tumors
At autopsy, the lungs were fixed by intratracheal
instillation of 10% neutralized formaldehyde. After
excision of the lungs, the number of pulmonary
tumors were counted under a dissecting microscope
w x23 . These tumors were embedded in paraffin, sec-
tioned and stained with hematoxylin and eosin for
histological confirmation.
2.8. Statistical analysis
Comparisons were performed by the chi-square
test for the percentage of tumor-bearing mice, and
other data were analyzed by one-way analysis of
variance followed by Duncan’s multiple-range test. A
P value of 0.05 or less was considered significant.
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3. Results
3.1. Time-course of change in pulmonary ODC acti˝-
ity after urethane injection
Time-course of change in pulmonary ODC activity
after urethane injection is illustrated in Fig. 1. ODC
activity after injection showed a biphasic increase.
The first peak of ODC activity was observed at day 3
after the injection, a subsequent second increase of
the activity began at day 14, and the increased level
had been maintained until day 70. In a previous
report on chemical-induced colon carcinogenesis, it is
indicated that an early peak of ODC activity is
associated with initiation phase and a second increase
w xis associated with promotion phase 24 . Additionally,
the time scale of urethane-induced lung carcino-
genesis in mice suggests that hyperplasia, micro-
scopic benign tumors and grossly visible benign tu-
mors were observed at 2, 4 and 10 weeks after the
w xinjection, respectively 25 . Based on these reports,
we selected the next points to assess pulmonary
polyamine biosynthesis and cell proliferation: at day
3 after urethane injection as the initiation phase; at
days 14 and 70 after the injection as the promotion
phase.
Fig. 1. Time-course of change in pulmonary ODC activity of
mice after urethane injection. Each point represents the mean
value and vertical lines indicate S.E. from four mice. ) Signifi-
cantly different from the activity at 0 h after the injection.
Fig. 2. The effect of vitamin E on pulmonary ODC activity at the
initiation and promotion phases of urethane-induced carcino-
genesis. Mice were killed at each point after urethane injection
indicated. Each column represents the mean value and vertical
lines indicate S.E. from five mice. ) Significantly different from
control. q Significantly different from urethane-treated group.
3.2. Effect of ˝itamin E on pulmonary ODC acti˝ity,
polyamine le˝el and cyclooxygenase acti˝ity during
urethane-induced carcinogenesis
The change in pulmonary ODC activity during the
urethane-induced lung carcinogenesis in each group
is shown in Fig. 2. At day 3 after urethane injection,
pulmonary ODC activity in urethane-treated group
showed a 130% increase and was significantly higher
than that in control group. About the increase by 70%
observed in the urethane-treated group was canceled
by vitamin E treatment, but no significant difference
was recognized between the urethane-treated and ure-
thane-plus-vitamin E-treated groups. At day 14 and
70 after the injection, the activities in the urethane-
treated groups showed statistical increases by 115%
and 92% compared with those in the control groups,
respectively. Most of the increase in the urethane-
treated group was inhibited by the vitamin E treat-
ment, and there was observed the significant differ-
ence. Furthermore, excessive feeding of vitamin E to
control group for 10 weeks had no influence on
 .pulmonary ODC activity unpublished data .
The effect of vitamin E on pulmonary polyamine
level during the urethane-induced lung carcinogenesis
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Table 1
Effect of vitamin E on pulmonary plyamine level at the initiation and promotion phases of urethane-induced carcinogenesis
a  .Treatment Period Polyamine level pmolrmg DNA
Putrescine Spermidine Spermine Total
Control 3 0.13"0.03 16.31"0.67 12.71"0.97 29.14"1.59
bUrethane 3 0.48"0.06 24.10"5.27 17.68"2.66 42.27"7.93
bUrethaneqvitamin E 3 0.35"0.11 17.17"1.22 15.64"2.20 33.39"2.49
Control 14 0.29"0.04 12.43"0.74 10.02"0.46 22.74"0.87
b bUrethane 14 0.42"0.08 15.37"0.72 11.81"0.71 26.97"0.91
c cUrethaneqvitamin E 14 0.29"0.03 13.12"0.58 10.39"0.43 23.79"1.01
Control 70 0.08"0.01 12.23"0.71 10.42"0.75 22.71"1.46
b bUrethane 70 0.21"0.01 15.37"0.72 11.75"1.08 26.45"2.13
c c cUrethaneqvitamin E 70 0.09"0.01 11.19"0.22 10.07"0.23 22.13"0.41
Mice were killed at each point after urethane injection indicated. Each value is the mean"S.E. of five mice.
a Days after urethane injection.
b Significantly different from control.
c Significantly different from urethane-treated group.
is summarized in Table 1. At all points tested in this
study, pulmonary putrescine level in the urethane-
treated group was higher than the level in control
group, and significant difference between the two
groups was observed except at day 14 after the
injection. Also, the urethane-induced increase of the
level at the initiation phase was higher than that at
Fig. 3. The effect of vitamin E on pulmonary cyclooxygenase
activity at the promotion phase of urethane-induced carcino-
genesis. Mice were killed at day 70 after the urethane injection.
Each column represents the mean value and vertical lines indicate
S.E. from four mice. ) Significantly different from control.
q Significantly different from urethane-treated group.
the promotion phase. Vitamin E could inhibit about
36% of the urethane-induced increase of the pu-
trescine level at the initiation phase. On the other
hand, the vitamin completely inhibited the increase of
the level at the promotion phase. These results pre-
sumably support the inhibitory effect of vitamin E on
the induction of ODC activity during the initiation
and promotion phases of the lung carcinogenesis.
With respect of the effect of vitamin E on spermi-
dine, spermine and total polyamine levels, the results
were similar to the result of putrescine level.
The effect of vitamin E on pulmonary cyclooxy-
genase activity at day 70 after urethane injection is
shown in Fig. 3. The activity in urethane-treated
group showed a 72% increase and was significantly
different compared to control group. Vitamin E could
inhibit about 30% of the urethane-induced elevation
of the activity, and the difference showed a statistical
significance.
3.3. Effect of ˝itamin E on pulmonary PCNA le˝el
during urethane-induced lung carcinogenesis
To determine if the inhibitory effect of vitamin E
on the urethane-induced pulmonary ODC induction
could contribute to the suppression of cell prolifera-
tion during the initiation and promotion phases of the
lung carcinogenesis, PCNA level, which was a useful
marker for cell proliferation, was determined by
western blot analysis using a specific antibody di-
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Table 2
Effect of vitamin E on urethane-induced lung carcinogenesis in mice
Group No. of No. of mice % of mice No. of No. of tumorsr
amice with tumors with tumors total tumors mouse
Control 10 0 0 0 0
Vitamin E 10 0 0 0 0
Urethane 10 10 100 95 9.5"1.2
b bUrethaneqVitamin E 10 8 80 56 5.6"1.0
a Values represent the mean"S.E.
b Significantly different from urethane-treated group.
rected against mouse PCNA. The result is shown in
Fig. 4A. Pulmonary PCNA level in the urethane-
treated group seemed to be higher than the level in
the control group, and vitamin E could bring the
 .Fig. 4. A Western blot analysis of PCNA level in lung tissues at
the initiation and promotion phases of urethane-induced carcino-
 .genesis and B the effect of putrescine treatment on the pul-
monary PCNA level at day 3 after the urethane injection. C,
control; U, urethane treatment; E, urethane plus vitamin E treat-
ment; EqP, urethane plus vitamin E plus putrescine treatment.
Three samples in each group were combined, and 20 mg protein
of the combined sample was applied to each lane. The experi-
mental design on putrescine treatment is described in Section 2.
increased level down to the control level. The values
for densitometric analyses of the bands were as fol-
lows each value represents % of each control
 .4100% : urethane treatment 147%, urethane plus vi-
 .tamin E treatment 82% at day 3 after the injection ;
urethane treatment 142%, urethane plus vitamin E
 .treatment 75% at day 14 after the injection ; ure-
thane treatment 196%, urethane plus vitamin E treat-
 .ment 137% at day 70 after the injection .
In order to clarify further if vitamin E-dependent
inhibition of polyamine biosynthesis contributed to
the suppression of PCNA level, the effect of pu-
trescine treatment on the level in urethane-plus-
vitamin E-treated group was estimated. As illustrated
in Fig. 4B, putrescine could bring the vitamin E-de-
creased level of PCNA up to the level in urethane-
treated group at day 3 after the urethane injection.
These result indicated that polyamine level was a
factor to regulate PCNA level in urethane-induced
lung carcinogenesis.
3.4. The effect of ˝itamin E on the de˝elopment of
lung tumors
The effect of vitamin E on urethane-induced lung
carcinogenesis in mice is summarized in Table 2.
Treatment of mice with urethane produced lung tu-
mors in 100% of the animals with an average of
9.5"1.2 tumors per mouse. Compared to the ure-
thane-treated mice, mice treated with urethane plus
vitamin E had a 20% lower incidence of lung tumors,
and reduced lung tumor levels by 41% 5.6"1.0
.tumors per mouse . The difference of these parame-
ters between the urethane-treated and urethane-plus-
vitamin E-treated groups was statistically significant.
Furthermore, excessive feeding of vitamin E to con-
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trol group had no effect on the development of lung
tumors. These results indicated that vitamin E could
suppress the development of lung tumors.
4. Discussion
In the present study, We suggested that vitamin E
suppressed the development of lung tumors in mice
treated with urethane due to the inhibition of
polyamine biosynthesis and subsequent cell prolifera-
tion during the initiation and promotion phases of the
lung carcinogenesis.
Uncontrollable cell proliferation might be associ-
w xated with carcinogenic process 1 . In fact, in the
gastrointestinal tracts, increased epithelial cell prolif-
eration is reported to increase the susceptibility to
w xtumor development 26 . It seems from the following
data that the induction of ODC activity and subse-
quent polyamine accumulation are essential for cell
 .proliferation during carcinogenesis: 1 The induction
of ODC activity and polyamine accumulation are
w x  .observed during the carcinogenesis 27 . 2 DFMO,
which is a irreversible inhibitor of ODC, has been
w x  .reported to inhibit chemical carcinogenesis 7,8 . 3
The induction of ODC activity precedes cell prolifer-
w x  .ation in many cells 1 . 4 Transfection of NIH 3T3
cells with a ODC gene elicited a complete morpho-
w xlogical transformation 28 . In our present study,
pulmonary ODC activity and polyamine level in-
creased during the urethane-induced carcinogenesis,
and the increases were suppressed by vitamin E
treatment. PCNA, a 36kDa auxiliary protein of DNA
polymerase, can be detected in the nuclei of prolifer-
ating cells in the G1 and S phases and a useful
w xmarker for cell proliferation 29 . The present experi-
ment indicated that the elevated level of pulmonary
PCNA during the lung carcinogenesis was decreased
by vitamin E treatment. The change of the PCNA
level was in agreement with the change of ODC
activity and polyamine level. Additionally, putrescine
treatment, a member of polyamine, could elevate the
lower level of PCNA in urethane-plus-vitamin E-
treated group up to the level in urethane-treated
group in the present study. Taking together, we can
account for the contribution of the activation of
polyamine biosynthesis to cell proliferation during
the urethane-induced lung carcinogenesis.
w xAs mentioned in Section 3, Luk et al. 24 has
reported that biphasic increase of colonic mucosal
ODC activity during chemical-induced colon carcino-
genesis and an early peak may relate to initiation
phase and a subsequent elevation may relate to pro-
motion phase. Also, it is known that phenolic com-
pound protocatechuric acid acts as a chemopreventive
agent against colon carcinogenesis due to lowering
cell proliferation through the suppression of ODC
w xinduction at the initiation and promotion phases 30 .
In the present study, we indicated that vitamin E
could reduce the induction of ODC activity and
subsequent cell proliferation during the initiation and
promotion phases of the lung carcinogenesis. Consid-
ering the significance of the inhibitory effect on the
ODC induction during the carcinogenesis, the inhibi-
tion at the initiation phase might to lead block the
fixation of DNA injury by cell proliferation, that is,
decrease the number of initiated cells, and the inhibi-
tion at the promotion phase might lower the prolifera-
tion of the initiated cells. As a result of the inhibition,
the development of lung tumors could be reduced. In
fact, we indicated that vitamin E suppressed all pa-
rameters on the development of lung tumors tumor
number per mouse and percentage of mice with
.tumors in this study. Overall, it is considered that
vitamin E acts as a useful chemopreventive agent to
reduce the development of lung tumors due to lower-
ing cell proliferation through the inhibition of the
ODC induction.
Some of factors contributing to the induction of
ODC during the promotion phase of carcinogenesis
have been determined. Increased level of prosta-
 .glandins PGs , particularly type-2 series such as
PGE , in the carcinogenic process correlated with the2
w xdevelopment of tumors 31 . Inhibitors of PG synthe-
sis such as indomethacin counteract the activity of a
tumor promoter, 12-o-tetradecanoyl-phorbol-13-
acetate in mouse skin carcinogenesis and also sup-
w xpress the induction of ODC in the epidermis 32 .
These findings suggest that PGs have a role in the
induction of ODC during the promotion phase of the
skin carcinogenesis. On the other hand, vitamin E can
reduce PGE synthesis through the inhibition of cy-2
w xclooxygenase 33 . We also found that vitamin E
could suppress pulmonary PGE synthesis at the2
promotion phase of the urethane-induced lung car-
cinogenesis through the inhibition of cyclooxygenase
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in the present study. Taking together, it seems that
vitamin E cancels the induction of ODC at the pro-
motion phase of the lung carcinogenesis partly due to
the reduction of PGE synthesis.2
Acknowledgements
We are grateful for the technical assistance of Miss
Yumi Obata. This work was supported in part by a
grant-in-aid for Science Research from the Ministry
of Health and Welfare of Japan and from the Min-
istry of Education, Culture and Science of Japan.
References
w x  .1 Janne, J., Poso, H. and Raina, A. 1978 Biochim. Biophys.
Acta 463, 241–293.
w x  .2 Tabor, C.W. and Taybor, H.A. 1976 Annu. Rev. Biochem.
45, 285–306.
w x3 Bull, A.W., Souillier, B.K., Wilson, P.S., Hayden, M. and
 .Nigro, N.D. 1979 Cancer Res. 39, 4956–4959.
w x  .4 Rozhin, J., Wilson, P.S., Bull, A.W. and Nigro, N.D. 1984
Cancer Res. 44, 3226–3230.
w x  .5 Pegg, A.E. 1988 Cancer Res. 48, 759–774.
w x  .6 Tamori, A., 1995 Cancer Res. 3500–3503.
w x7 Weeks, C.E., Herrmann, A.L., Nelson, F.R. and Slaga, T.J.
 .1982 Proc. Natl. Acad. Sci. USA. 79, 6028–6032.
w x  .8 Homma, Y., Kakizoe, T., Samma, S. and Oyasu, R. 1987
Cancer Res. 47, 6176–6179.
w x  .9 Chen, L.H., Bossionneault, G.A. and Glauert, H.P. 1988
Anticancer Res. 8, 739–748.
w x  .10 Witting, L.A. 1990 in Free Radicals in Biology Vol.4
 .Pryor, W.A., ed. , pp. 295–319, Academic Press, New
York.
w x  .11 Cook, M.G. and McNamara, P. 1980 Cancer Res. 40,
1329–1331.
w x12 Meydani, S.N., Barklund, M.P., Liu, S., Meydani, M., Miller,
R.A., Cannon, J.G., Morrow, F.D., Rochlin, R. and Blum-
 .berg, J.B. 1990 Am. J. Clin. Nutr. 52, 557–563.
w x  .13 Yoshimura, K., Yamashita, N. and Ishikawa, H. 1980
 .Nihon-Rinsho, 38, 2581–2591 in Japnese .
w x  .14 Yano, T., Ishikawa, G. and Ichikawa, T. 1993 Carcinogen-
esis 14, 1133–1136.
w x15 Otani, S., Matsui, I., Nakajima, S., Matsutani, M., Mi-
 .zoguchi, S. and Morisawa, S. 1980 J. Biochem. 88, 77–85.
w x16 Matsui-Yuasa, I., Obayashi, M., Hasuma, T. and Otani, S.
 .1992 Chem-Biol. Inter. 21, 233–239.
w x  .17 Daniel, F.B., Haas, D.L. and Pyle, S.M. 1985 Anal.
Biochem. 144, 390–402.
w x18 Kitada, M., Igarashi, T., Kamataki, T. and Kitagawa, H.
 .1978 Jpn. J. Pharmacol. 27, 481–489.
w x  .19 Yamaki, K. and Ohishi, S. 1989 J. Pharmacobiodyn. 12,
74–79.
w x20 Higaki, I., Matsui-Yuasa, I., Terakura, M., Kinoshita, H.
 .and Otani, S. 1994 Gastroenterology 106, 1024–1031.
w x  .21 Laemmli, U.K. 1970 Nature 227, 680–685.
w x  .22 Towbin, H., Stachelin, T. and Gordon, J. 1979 Proc. Natl.
Acad. Sci. USA 76, 4350–4354.
w x23 Witschi, H., Malkinson, A.M., Peraino, C., Russell., J.J. and
 .Staffeld, E.F. 1989 Fund. Appl. Toxicol. 13, 174–180.
w x24 Luk, G.D., Hamilton, S.R., Yang, P., Smith, J.A.,
 .O’Cealaigh, D., McAvinchey, D. and Hyland 1986 Cancer
Res. 46, 4449–4452.
w x  .25 Malkinson, A.M. 1992 Cancer Res. 52, 2670s–2676s.
w x  .26 Lipkin, M. 1988 Cancer Res. 48, 235–245.
w x  .27 O’Brien, T.G. 1976 Cancer Res. 36, 2644–2653.
w x28 Auvineu, M., Paasineu, A., Andersson, L.C. and Holtta, E.
 .1992 Nature 360, 355–358.
w x29 Lee, J.S., Lippman, S.M., Hong, W.K., Ro, J.Y., Kim, S.Y.,
 .Lotan, R. and Hittelman, W.N. 1992 Cancer Res. 52,
2707s–2710s.
w x  .30 Tanaka, T., Kojima, T., Suzuki, M. and Mori, H. 1993
Cancer Res. 53, 3908–3913.
w x  .31 Narisawa, T., Satoh, M. and Takahashi, T. 1983 Carcino-
genesis 4, 1225–1227.
w x  .32 Verma, A.K., Ashendel, C.L. and Boutwell, R.K. 1980
Cancer Res. 47, 5340–5346.
w x33 Sakamoto, W., Fujie, K., Handa, H., Nishihira, J. and Mino,
 .M. 1991 Biochim. Biophys. Acta 1074, 251–255.
